ArticleCancer science2023

Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment.

Takayuki Ikezoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.